Further analysis of the antinociceptive action caused by p-methoxyl-diphenyl diselenide in mice

Pharmacology Biochemistry and Behavior

Volumn 91, Issue 4, 2009, Pages 573-580

  Jesse, Cristiano R ^a   Rocha, Joao B T ^a   Nogueira, Cristina W ^a   Savegnago, Lucielli ^b  

^a Reatividade e Avaliacao Farmacologica e Toxicologica de Organocalcogenios   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

Antinociceptive; Mechanisms of action; Mice; Organoselenium; Selenium

Indexed keywords

4 METHOXYL DIPHENYL DISELENIDE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ANTINOCICEPTIVE AGENT; ARGININE; BRADYKININ; BRADYKININ DERIVATIVE; CAFFEINE; DOPAMINE 1 RECEPTOR; GLUTAMIC ACID; KETANSERIN; KININ; KININ B1 RECEPTOR; KININ B2 RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N(G) NITROARGININE; NALOXONE; ONDANSETRON; PHORBOL 13 ACETATE 12 MYRISTATE; PINDOLOL; PRAZOSIN; PROTEIN KINASE C; SEROTONIN RECEPTOR; SULPIRIDE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; MALE; MOUSE; NITRERGIC NERVE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL;

MUS;

EID: 84984569833     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.09.012     Document Type: Article

References (56)

1. Alhaider A.A., Lei S.Z., and Wilcox G.L. Spinal 5-HT3 receptor-mediated antinociception: possible release of GABA. J Neurosci 11 (1991) 1881-1888
2. Beirith A., Santos A.R.S., and Calixto J.B. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res 924 (2002) 219-228
3. Beirith A., Santos A.R.S., and Calixto J.B. The role of neuropeptides and capsaicin-sensitive fibers in glutamate-induced nociception and paw oedema in mice. Brain Res 969 (2003) 110-116
4. Besson J.M. The neurobiology of pain. Lancet 353 (1999) 1610-1615
5. Calixto J.B., Cabrini D.A., Ferreira J., and Campos M.M. Kinins in pain and inflammation. Pain 87 (2000) 1-5
6. Calixto J.B., Cabrini D.A., Ferreira J., and Campos M.M. Inflammatory pain: kinins and antagonists. Curr Opin Anaesthesiol 14 (2001) 519-526
7. 2 receptors in bradykinin-induced rat paw oedema. Br J Pharmacol 114 (1995) 1005-1013
8. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br J Pharmacol 117 (1996) 793-798
9. 1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci 27 (2006) 646-651
10. Choi S.S., Han K.J., Lee J.K., Lee H.K., Han E.J., Kim D.H., et al. Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci 73 (2003) 471-485
11. Chung K.M., Choi S.S., Han K.J., Han E.J., Lee H.K., and Suh H.W. Antinociceptive effects of methylsergide in various pain models. Pharmacology 69 (2003) 93-101
12. Dray A., and Perkins M.N. Kinins and pain. In: Farmer S.G. (Ed). The kinin system (1997), Academic Press, San Diego, CA 157-172
13. Elisabetsky E., and Castilhos Z.C. Plants used as analgesics by Amazonian Caboclos, as a basis for selecting plants for investigation. Int J Crude Drug Res 28 (1990) 309-320
14. 2 kinin receptor activation in mice. Br J Pharmacol 141 (2004) 787-794
15. Ferreira J., Trichês K.M., Medeiros R., and Calixto J.B. Mechanisms involved in the nociception produced by peripheral protein kinase C activation in mice. Pain 117 (2005) 171-181
16. 1 receptors in the nociception produced by peripheral protein kinase C activation in mice. Neuropharmacology 54 (2008) 597-604
17. Fürst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 48 (1999) 129-141
18. Gao X., Zhang Y., and Wu G. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats. Eur J Pharmacol 418 (2001) 73-77
19. 2 receptor binding in atypical facial pain. Pain 106 (2003) 43-48
20. Jaaskelainen S.K., Rinne J.O., Forssell H., Tenovuo O., Kaasinem V., Sonninem P., et al. Role of the dopaminergic system in chronic pain-a fluorodopa-PET study. Pain 90 (2001) 257-260
21. Jackson D.L., Graff C.B., Richardson J.D., and Hargreaves K.M. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur J Pharmacol 284 (1995) 321-325
22. Julius D., and Basbaum A.I. Molecular mechanisms of nociception. Nature 413 (2001) 203-210
23. Katzung, B.G. Basic and Clinical Pharmacology. 8th ed. Appleton and Lange. USA. 2001.pp. 523-525, 602-605.
24. Luiz A.P., Moura J.D., Meotti F.C., Gukinski G., Guimarães C.L.S., Azevedo M.S., et al. Antinociceptive action of ethanolic extract obtained from roots Humirianthera ampla Miers. J Ethnopharmacol 114 (2007) 355-363
25. Lyons C.R. The role of nitric oxide in inflammation. Adv Immunol 60 (1995) 323-371
26. Malmberg A.B., and Yaksh T.L. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 54 (1993) 291-300
27. Marcinkiewicz J., Grabowska A., and Chain B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur J Pharmacol 285 (1995) 947-951
28. McNearney T., Speegle D., Lawand N.B., Lisse J., and Westlund K.N. Excitatory amino acid profiles of synovial fluid derived from patients with arthritis. J Rheumatol 27 (2000) 739-745
29. Meller S.T., Cykstra C., and Gebhart G.F. Acute thermal hyperalgesia in the rat is produced by activation of NMDA receptors and protein kinase C and production of nitric oxide. Neuroscience 71 (1996) 327-335
30. Melzack R. Pain-an overview. Acta Anaesthesiol Scand 43 (1999) 880-884
31. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-374
32. Morgan M.J., and Franklin K.B. Dopamine receptor subtypes and formalin test analgesia. Pharmacol Biochem Behav 40 (1991) 317-322
33. Nogueira C.W., Quinhones E.B., Jung E.A.C., Zeni G., and Rocha J.B.T. Anti-inflamatory and antinociceptive activity of diphenyl diselenide. Inflamm Res 52 (2003) 56-63
34. Nogueira C.W., Zeni G., and Rocha J.B.T. Organosellenium and organotellurium compounds: pharmacology and toxicology. Chem Rev 104 (2004) 6255-6286
35. Parnham M.J., and Graf E. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem Pharmacol 36 (1987) 3095-3102
36. Paulmier C. Selenoorganic functional groups. In: Paulmier C. (Ed). Selenium reagents and intermediates in organic synthesis. 1 ed. (1986), Pergamon Press, Oxford 25-51
37. Pietrovski E.F., Rosa K.A., Facundo V.A., Rios K., Marques M.C., and Santos A.R.S. Antinociceptive properties of the ethanolic extract and of the triterpene 3β,6β,16β-trihidroxilup-20(29)-ene obtained from the flowers of Combretum leprosum in mice. Pharmacol Biochem Behav 83 (2006) 90-99
38. Pinto L.G., Jesse C.R., Nogueira C.W., and Savegnago L. Evidence for the involvement of glutamatergic and GABAergic systems and protein kinase A pathway in the antinociceptive effect caused by p-methoxy-diphenyl diselenide in mice. Pharmacol Biochem Behav 88 (2008) 487-496
39. Prigol M., Wilhelm E.A., Schneider C.C., Rocha J.B.T., Nogueira C.W., and Zeni G. Involvement of oxidative stress in seizures induced by diphenyl diselenide in rat pups. Brain Res 1147 (2007) 226-232
40. i/o protein in the antinociceptive action of the gallic acid ethyl ester. Eur J Pharmacol 379 (1999) 7-17
41. Santos A.R.S., Gadotti V.M., Oliveira G.L., Tibola D., Paszuk A.F., Neto A., et al. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology 48 (2005) 1021-1034
42. Sautebin L., Ialenti A., Ianaro A., and Di Rosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol 114 (1995) 323-328
43. Savegnago L., Pinto L.G., Jesse C.R., Alves D., Rocha J.B.T., Nogueira C.W., et al. Antinociceptive properties of diphenyl diselenide: evidences for the mechanism of action. Eur J Pharmacol 555 (2007) 129-138
44. Savegnago L., Pinto L.G., Jesse C.R., Rocha J.B.T., Nogueira C.W., and Zeni G. Spinal mechanisms of antinociceptive action caused by diphenyl diselenide. Brain Res 1162 (2007) 32-37
45. Savegnago L., Jesse C.R., Pinto L.G., Rocha J.B.T., and Nogueira C.W. Diphenyl diselenide attenuates acute thermal hyperalgesia and persistent inflammatory and neuropathic pain behavior in mice. Brain Res 1175 (2007) 54-59
46. Savegnago L., Jesse C.R., Pinto L.G., Rocha J.B.T., Nogueira C.W., and Zeni G. Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1261-1269
47. 2B antagonist but not imidazoline receptor antagonists modulate antinociception induced by diphenyl diselenide in mice. Neurosci Lett 436 (2008) 120-123
48. Sawynok J., and Reid A. Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception. Behav Brain Res 73 (1996) 63-68
49. Schewe T. Molecular actions of ebselen-an anti-inflammatory antioxidant. Gen Pharmacol 26 (1995) 1153-1169
50. Siebel J.S., Beirith A., and Calixto J.B. Evidence for the involvement of metabotropic glutamatergic, neurokinin 1 receptor pathways and protein kinase C in the antinociceptive effect of dipyrone in mice. Brain Res 1003 (2004) 61-67
51. Souza A.L., Moreira F.A., Almeida K.R., Bertollo C.M., Costa K.A., and Coelho M.M. In vivo evidence for a role of protein kinase C in peripheral nociceptive processing. Br J Pharmacol 88 (2002) 544-548
52. 1 receptor antagonist attenuates the 4-beta-phorbol-12-myristate-13-acetate-induced nociceptive behaviour in the rat. Eur J Pharmacol 507 (2005) 29-34
53. Zarrindast M.R., Nassiri-Rad S., and Pazouki M. Effect of dopaminergic agents on antinociception in formalin test. Gen Pharmacol 32 (1999) 517-522
54. Zasso F.B., Gonçales C.E.P., Jung E.A.C., Araldi D., Zeni G., Rocha J.B.T., et al. On the mechanisms involved in antinociception induced by diphenyl diselenide. Environ Toxicol Pharmacol 19 (2005) 283-289
55. Zhou S., Bonasera L., and Carlton S.M. Peripheral administration of NMDA, AMPA or KA results in pain behaviours in rats. Neuroreport 7 (1996) 895-900
56. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110